June 5, 2024
Dr. Robert CG Martin II, M.D, PhD Presenting his IRE Data at the Central Surgical Association 81st Annual Meeting
Immunophotonics is excited to share that Dr. Robert CG Martin II, M.D, PhD, PACS, who serves as Principal Investigator and...
Read More
May 30, 2024
ASCO Chicago, May 31 – June 3, 2024
Immunophotonics co-founders Lu Alleruzzo (CEO) and Tomas Hode, PhD (CIO and President) will be in Chicago at the ASCO (American...
Read More
April 30, 2024
Immunophotonics Announces the Addition of Jacqueline Hess to its Advisory Board
Immunophotonics, Inc. is delighted to introduce Jacqueline Hess as the newest addition to our advisory board. Ms. Hess has over 25 years...
Read More
April 24, 2024
European Conference on Interventional Oncology (ECIO), April 28 – May 1, 2024
Tomas Hode, PhD, who serves as the Co-Founder, CIO, and President at Immunophotonics, Inc., will be attending the European Conference...
Read More
April 19, 2024
Swiss Biotech Day, April 22 – 23, 2024
Immunophotonics is thrilled to share that Dr. Theresa Visarius from Immunophotonics Switzerland (IPS Biopharma) will be attending the Swiss Biotech...
Read More
March 20, 2024
AngioDynamics International Life Symposium “The Human Touch, Behind Innovation” March 21–23, 2024
Tomas Hode, PhD, who serves as the Co-Founder, CIO, and President at Immunophotonics, Inc. is eager to attend the AngioDynamics...
Read More
March 13, 2024
MOBIO to feature Immunophotonics as the Member Highlight for March
Immunophotonics to be showcased as the Member Highlight for March by The Missouri Biotechnology Association (MOBIO), both on their homepage...
Read More
February 28, 2024
AngioDynamics and Immunophotonics Announces Partnership to Explore the Power of Immunotherapy
Immunophotonics Lu Alleruzzo, CEO and Tomas Hode, PhD, CIO, and President have announced a partnership that will combine use of...
Read More
February 23, 2024
Immunophotonics presenting at the Global Life Science Partnering & Investor Conference February 27-29, 2024
Immunophotonics, Inc. is grateful to NCI (National Cancer Institute) SBIR Investor Initiatives Team for providing us the opportunity to showcase...
Read More
February 13, 2024
Wei Chen’s Publication in Acta Biomaterialia Journal
Congratulations to Professor Wei Chen and his lab at the University of Oklahoma, along with contributors Lu Alleruzzo, Samuel S.K....
Read More